Rare Diseases
Latest News
Topical treatment for EB recommended for approval in the EU
“The benefit of Filsuvez is its ability to promote healing of EB partial thickness wounds,” the EMA said in an announcement.
From the Journals
IV gentamicin improves junctional epidermolysis bullosa in children
After treatment, each of the children had increased, sustained expression of laminin 332.
Conference Coverage
Dupilumab treats itch and clears lesions in prurigo nodularis patients
There are currently no Food and Drug Administration–approved systemic therapies for PN.
Conference Coverage
Novel isotretinoin ointment for congenital ichthyosis shows promise
“There is currently no FDA-approved drug for congenital ichthyosis,” Dr. Christopher G. Bunick said.
Original Research
Morphology of Mycosis Fungoides and Sézary Syndrome in Skin of Color
Dermatologists should be familiar with the variable morphology of mycosis fungoides (MF)/Sézary syndrome (SS) exhibited by patients of all skin...
Latest News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
Latest News
U.S. FDA declines to approve Amryt’s topical gel for rare skin diseases
The decision comes after the FDA had extended its review of the treatment, oleogel-S10, in November by three months to review additional analyses...
Latest News
Lipedema: A potentially devastating, often unrecognized disease
“If patients with lipedema gain weight, the problem becomes even worse,” Dr. C. William Hanke said.
Latest News
Superficial radiotherapy tied to remission, better quality of life in severe Hailey-Hailey disease
To explore the use of superficial radiotherapy, the investigators analyzed data on 13 patients who received the treatment.
From the Journals
Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasis
“These case series confirm the rarity of both generalized pustular psoriasis and palmoplantar pustulosis ... and the lack of effective treatment...
From the Journals
Spesolimab speeds lesion clearance in generalized pustular psoriasis
Patients treated with intravenous spesolimab showed significant clearance, but also susceptibility to infections.